A review of certain current private member's bills before Parliament reveal that important changes are being sought to both patent and food and drug legislation. We will report further if these bills progress.
Bill C-275, which had a first reading on January 29, 2009, seeks to reduce the extent of patent protection for medicines by amendment of section 55.2(4) of the Patent Act and by repeal of the Patented Medicines (Notice of Compliance) Regulations.
Bill C-370 was first read on April 27, 2009. This bill seeks to amend the Food and Drug legislation to require identification of and labelling of genetically modified foods.
Finally, most recently, Bill C-393/S-232 had a first reading May 25, 2009. This Bill seeks to amend the Patent Act and the Food and Drugs Act pertaining to the Jean Chretien Pledge to Africa legislation. In particular the Bill summary indicates that it seeks to make it easier to manufacture and export pharmaceutical products to developing and least developed countries.
For more information, please see: For Bill C-275, http://www2.parl.gc.ca/HousePublications/Publication.aspx?Docid=3633857&file=4